Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),Other Cancers CEMI Monotherapy as 1L Treatment of Pts With Brain Metastases From aNSCLC Aug 07, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) 1L Cemiplimab for laNSCLC: Updated Subgroup Analyses Aug 03, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Updated Efficacy and Safety of Taletrectinib in Pts With ROS1+ NSCLC Jul 31, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Updated Data on DFS, OS, and Safety in Pts Receiving Adj Atezo After Neoadj Atezo Jul 31, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tumor Growth Inhibition-OS Model: Alectinib Data Validation Jul 27, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Atezolizumab Monotherapy vs Single-Agent Chemotherapy in Platinum-Ineligible NSCLC Patients Jul 19, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),Other Cancers Entrectinib Demonstrates Safety and Effectiveness in Metastatic ROS1 Fusion-Positive Lung Cancer Jun 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) KEYNOTE-010 Study: Pembrolizumab Shows Long-Term Survival Benefit in Advanced NSCLC Jun 30, 2023
